Neal D. Shore, MD, FACS

Dr. Neal Shore is the Medical Director for the Carolina Urologic Research Center. He practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina.

Dr. Shore has conducted more than 350 clinical trials focusing mainly on GU Oncology, and serves on the Executive Boards of the following: Society of Urologic Oncology, Bladder Cancer Advocacy Network, Society of Urologic Oncology Clinical Trials Consortium and is President of LUGPA. He is a founder of the CUSP Clinical Trials Consortium as well as DASHKO (large urology practices data registries). He serves as the National Urology Research Director for 21st Century Oncology. He has served on the AUA Male Health Committee and the AUA Data Committee, the SITC Task Force for Prostate Cancer, the Bladder Cancer Advocacy Think Tank, and the editorial boards of Reviews in Urology, Urology Times, Chemotherapy Advisor, OncLive, PLOS ONE, Urology Practice, World Journal of Urology, and serves as Editor for Everyday Urology-Oncology. He has written more than 125 peer-reviewed publications and numerous book chapters. He performs peer review for Lancet Oncology, European Urology, Journal Urology, Urology, BJUI, PCPD, and numerous other high-impact scientific journals.

A graduate of Duke University and Duke University Medical School, Dr. Shore completed a six-month clinical research fellowship in Pretoria, South Africa, and then completed his General Surgery/Urology training at New York Hospital Cornell Medical Center and at Memorial Sloan-Kettering Cancer Center in New York City. He is a Fellow of the American College of Surgeons.